Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
2013; Springer Nature; Volume: 28; Issue: 1 Linguagem: Inglês
10.1038/leu.2013.232
ISSN1476-5551
AutoresLeila R. Martins, Paulo Lúcio, Alice Melão, Inês Antunes, Bruno A. Cardoso, Ryan Stansfield, Maria Teresa Sabrina Bertilaccio, Paolo Ghia, Denis Drygin, María Gomes da Silva, João T. Barata,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoActivity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
Referência(s)